Lexaria Bioscience Corp (NAS:LEXXW) Stock News, Headlines & Updates
Lexaria Bioscience Corp Stock News from GuruFocus
- 1
Jun 18, 2024
Lexaria Awards CRO Contract for 12-Week DehydraTECH GLP-1 Chronic Human Study
ACCESSWIRE • 11:00am
Jun 05, 2024
Dosing Continues in Lexaria's Second GLP-1 Human Pilot Study
ACCESSWIRE • 11:00am
May 23, 2024
Lexaria Awards Contract For Third GLP-1 Human Pilot Study
ACCESSWIRE • 11:00am
May 21, 2024
Lexaria Receives Two New Medical-Treatment Patents in Hypertension and Epilepsy
ACCESSWIRE • 11:00am
May 17, 2024
Dosing Begins in Lexaria's Comprehensive GLP-1 Animal Study
ACCESSWIRE • 11:00am
May 08, 2024
Lexaria Begins Dosing of Its Second GLP-1 Human Pilot Study
ACCESSWIRE • 11:00am
May 06, 2024
Lexaria Announces New Research Program to Evaluate Mode of Action and Performance of DehydraTECH-GLP-1 Drugs
ACCESSWIRE • 11:00am
Apr 30, 2024
Lexaria to Receive $4.7 Million Gross Proceeds in Warrant Exercise and Issuance
ACCESSWIRE • 3:00pm
Apr 16, 2024
Lexaria Receives Ethics Review Board Approval to Begin New GLP-1 Study
ACCESSWIRE • 11:00am
Apr 02, 2024
Lexaria Awarded New Patents
ACCESSWIRE • 11:00am
- 1
Show
Entries
Headlines
Total 0- 1
No recent news